EPIRUS Biopharmaceuticals, Inc. is a biopharmaceutical company, which focuses on building a biosimilar business. It focuses on biosimilars, which are biologic drugs that are demonstrated to be highly similar to a previously approved biologic drug, known as a reference product. The company was founded on November 26, 2008 and is headquartered in Boston, MA.
Company profile
Ticker
EPRSQ
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Combinatorx Inc, Combinatorx, Inc, Zalicus Inc.
SEC CIK
Corporate docs
IRS number
43514457
EPRSQ stock data
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
15 May 24
25-NSE
Exchange delisting
26 Sep 16
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1 Aug 16
8-K
Entry into a Material Definitive Agreement
25 Jul 16
8-K
Entry into a Material Definitive Agreement
1 Jul 16
8-K
Entry into a Material Definitive Agreement
14 Jun 16
10-Q
2016 Q1
Quarterly report
10 May 16
8-K
EPIRUS Announces Reprioritization of Pipeline to Solely Focus on Biosimilars to Treat Rare Diseases and Key Leadership Changes
9 May 16
10-K/A
2015 FY
Annual report (amended)
29 Apr 16
10-K
2015 FY
Annual report
29 Mar 16
Latest ownership filings
SC 13G/A
EPIRUS Biopharmaceuticals, Inc.
14 Feb 17
SC 13G/A
EPIRUS Biopharmaceuticals, Inc.
11 Jul 16
SC 13G/A
EPIRUS Biopharmaceuticals, Inc.
11 Jul 16
SC 13G/A
EPIRUS Biopharmaceuticals, Inc.
8 Jul 16
4
Michael Wyand
31 May 16
4
Robert Ticktin
31 May 16
4
Vincent Aurentz
31 May 16
4
Thomas A. Shea
31 May 16
4/A
Michael Wyand
11 Mar 16
4
Amit Munshi
1 Mar 16
Institutional ownership, Q3 2019
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 400.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Private Capital | 400.00 | $0.00 |